Erratum to: Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability : Mapping Fragile Sites in Epithelial Cells (Genes, Chromosomes and Cancer, (2013), 52, 11, (1017-1029), 10.1002/gcc.22097);Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability

Genes Chromosomes and Cancer

Volumn 52, Issue 11, 2013, Pages 1017-1029

  Hosseini, Seyed Ali ^a   Horton, Susan ^a   Saldivar, Joshua C ^a   Miuma, Satoshi ^a   Stampfer, Martha R ^b   Heerema, Nyla A ^a   Huebner, Kay ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN; GENTAMICIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL STRAIN HCT116; CHROMOSOME 2Q; CHROMOSOME BAND; CHROMOSOME FRAGILE SITE; CHROMOSOME XQ; COPY NUMBER VARIATION; DNA DAMAGE; DNA REPLICATION; EPITHELIUM CELL; FHIT GENE; FIBROBLAST; GENE; GENE PRODUCT; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; LYMPHOBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

MURINAE;

EID: 84884700936     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22797     Document Type: Erratum

References (51)

1. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Bartek J. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-870.
2. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, Widaa S, Hinton J, Fahey C, Fu B, Swamy S, Dalgliesh GL, Teh BT, Deloukas P, Yang F, Campbell PJ, Futreal PA, Stratton MR. 2010. Signatures of mutation and selection in the cancer genome. Nature 463:893-898.
3. Boberg DR, Batistela MS, Pecharki M, Ribeiro EM, Cavalli IJ, Lima RS, Urban CA, Furtado-Alle L, Souza RL. 2013. Copy number variation in ACHE/EPHB4 (7q22) and in BCHE/MME (3q26) genes in sporadic breast cancer. Chem Biol Interact 203:344-347.
4. Brown KK, Alkuraya FS, Matos M, Robertson RL, Kimonis VE, Morton CC. 2009. NR2F1 deletion in a patient with a de novo paracentric inversion, inv(5)(q15q33.2), and syndromic deafness. Am J Med Genet A 149:931-938.
5. Cengiz B, Gunduz M, Nagatsuka H, Beder L, Gunduz E, Tamamura R, Mahmut N, Fukushima K, Ali MA, Naomoto Y, Shimizu K, Nagai N. 2007. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer. Oral Oncol 43:241-247.
6. Chien J, Narita K, Rattan R, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Roberts LR, Molina J, Kaufmann SH, Prendergast GC, Shridhar V. 2008. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Oncogene 27:7223-7234.
7. Consortium EP. 2011. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 9:e1001046.
8. Consortium EP. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74.
9. Debatisse M, Le Tallec B, Letessier A, Dutrillaux B, Brison O. 2012. Common fragile sites: Mechanisms of instability revisited. Trends Genet 28:22-32.
10. Djalali M, Adolph S, Steinbach P, Winking H, Hameister H. 1987. A comparative mapping study of fragile sites in the human and murine genomes. Hum Genet 77:157-162.
11. Dohi O, Takada H, Wakabayashi N, Yasui K, Sakakura C, Mitsufuji S, Naito Y, Taniwaki M, Yoshikawa T. 2010. Epigenetic silencing of RELN in gastric cancer. Int J Oncol 36:85-92.
12. Finch R, Moore HG, Lindor N, Jalal SM, Markowitz A, Suresh J, Offit K, Guillem JG. 2005. Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: Report of a case. Dis Colon Rectum 48:2148-2152.
13. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA, Jr., Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. 2005. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-913.
14. Grady B, Goharderakhshan R, Chang J, Ribeiro-Filho LA, Perinchery G, Franks J, Presti J, Carroll P, Dahiya R. 2001. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma. J Urol 166:1088-1092.
15. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K. 2004. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 100:1605-1614.
16. Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudsen LE, Norppa H, Reuterwall C. 1998. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117-4121.
17. Hansen RS, Thomas S, Sandstrom R, Canfield TK, Thurman RE, Weaver M, Dorschner MO, Gartler SM, Stamatoyannopoulos JA. 2010. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc Natl Acad Sci USA 107:139-144.
18. Huebner K. 2011. DNA fragility put into context. Nature 470:46-47.
19. Huebner K, Croce CM. 2001. FRA3B and other common fragile sites: The weakest links. Nat Rev Cancer 1:214-221.
20. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsiere T. 2008. Genetic polymorphisms and micronucleus formation: A review of the literature. Mutat Res 658:215-233.
21. Jongsma AP, Piek JM, Zweemer RP, Verheijen RH, Klein Gebbinck JW, van Kamp GJ, Jacobs IJ, Shaw P, van Diest PJ, Kenemans P. 2002. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. Mol Pathol 55:305-309.
22. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP. 2010. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One 5:e9201.
23. Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, Smith AE, Prat A, Perou CM, Gilmore H, Schnitt S, Naber SP, Garlick JA, Kuperwasser C. 2012. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA 109:2772-2777.
24. Kim YH, Lachuer J, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nobusawa S, Nakazato Y, Tanaka Y, Vital A, Mariani L, Ohgaki H. 2011. Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations. Brain Pathol 21:645-651.
25. Kohno T, Otsuka T, Inazawa J, Abe T, Yokota J. 1996. Breakpoint junction of interstitial homozygous deletion at chromosome 2q33 in a small cell lung carcinoma. DNA Res 3:421-424.
26. Krummel KA, Denison SR, Calhoun E, Phillips LA, Smith DI. 2002. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer 34:154-167.
27. Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Lee HK, Park JY, Oh RR, Jang JJ, Park KM, Han JY, Kang CS, Lee JY, Yoo NJ. 1999. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas. Cancer Res 59:5674-5677.
28. Letessier A, Millot GA, Koundrioukoff S, Lachages AM, Vogt N, Hansen RS, Malfoy B, Brison O, Debatisse M. 2011. Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470:120-123.
29. Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM. 2000. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 60:1177-1182.
30. Mrasek K, Schoder C, Teichmann AC, Behr K, Franze B, Wilhelm K, Blaurock N, Claussen U, Liehr T, Weise A. 2010. Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int J Oncol 36:929-940.
31. Murano I, Kuwano A, Kajii T. 1989a. Cell type-dependent difference in the distribution and frequency of aphidicolin-induced fragile sites: T and B lymphocytes and bone marrow cells. Hum Genet 84:71-74.
32. Murano I, Kuwano A, Kajii T. 1989b. Fibroblast-specific common fragile sites induced by aphidicolin. Hum Genet 83:45-48.
33. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability-An evolving hallmark of cancer. Nat Rev Mol Cell Biol 11:220-228.
34. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
35. Ozeri-Galai E, Bester AC, Kerem B. 2012. The complex basis underlying common fragile site instability in cancer. Trends Genet 28:295-302.
36. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. 2002. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16:948-958.
37. Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VV. 2004. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4:5.
38. Rothenberg SM, Mohapatra G, Rivera MN, Winokur D, Greninger P, Nitta M, Sadow PM, Sooriyakumar G, Brannigan BW, Ulman MJ, Perera RM, Wang R, Tam A, Ma XJ, Erlander M, Sgroi DC, Rocco JW, Lingen MW, Cohen EE, Louis DN, Settleman J, Haber DA. 2010. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res 70:2158-2164.
39. Saldivar JC, Miuma S, Bene J, Hosseini SA, Shibata H, Sun J, Wheeler LJ, Mathews CK, Huebner K. 2012. Initiation of genome instability and preneoplastic processes through loss of Fhit expression. PLoS Genet 8:e1003077.
40. Seabright M. 1971. A rapid banding technique for human chromosomes. Lancet 2:971-972.
41. Simoneau M, LaRue H, Aboulkassim TO, Meyer F, Moore L, Fradet Y. 2000. Chromosome 9 deletions and recurrence of superficial bladder cancer: Identification of four regions of prognostic interest. Oncogene 19:6317-6323.
42. Sonoda E, Sasaki MS, Morrison C, Yamaguchi-Iwai Y, Takata M, Takeda S. 1999. Sister chromatid exchanges are mediated by homologous recombination in vertebrate cells. Mol Cell Biol 19:5166-5169.
43. Soule HD, Maloney TM, Wolman SR, Peterson WD, Jr., Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
44. Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S. 1998. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58:5032-5037.
45. Stampfer MR, Bartley JC. 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci USA 82:2394-2398.
46. Stankov K, Pastore A, Toschi L, McKay J, Lesueur F, Kraimps JL, Bonneau D, Gibelin H, Levillain P, Volante M, Papotti M, Romeo G. 2004. Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Int J Cancer 111:463-467.
47. Turner BC, Ottey M, Zimonjic DB, Potoczek M, Hauck WW, Pequignot E, Keck-Waggoner CL, Sevignani C, Aldaz CM, McCue PA, Palazzo J, Huebner K, Popescu NC. 2002. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. Cancer Res 62:4054-4060.
48. Wistuba, II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, III, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD. 2000. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 60:1949-1960.
49. Worsham MJ, Benninger MJ, Zarbo RJ, Carey TE, Van Dyke DL. 1993. Deletion 9p22-pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes Chromosomes Cancer 6:58-60.
50. Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, van Spaendonk R, Wolman SR. 2006. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat 96:177-186.
51. Zhu Y, McAvoy S, Kuhn R, Smith DI. 2006. RORA, a large common fragile site gene, is involved in cellular stress response. Oncogene 25:2901-2908.